ORG-9426

Known as: ORG 9426 
 

Topic mentions per year

Topic mentions per year

1990-2003
0246819902003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
BACKGROUND Rocuronium (ORG 9426) is a new nondepolarizing neuromuscular blocking agent with a rapid onset and an intermediate… (More)
Is this relevant?
1993
1993
The pharmacodynamics of an initial dose of 0.6 mg.kg-1 rocuronium followed by three maintenance doses of 0.15 mg.kg-1 were… (More)
Is this relevant?
1992
1992
To determine the effect of end-stage renal disease on the pharmacokinetics of reocuronium bromide (ORG 9426), a new… (More)
Is this relevant?
1992
1992
The potency of ORG 9426, a new nondepolarising muscle relaxant, has been estimated using two different modes of nerve stimulation… (More)
Is this relevant?
1992
1992
The effects of rocuronium, 0.25 or 0.5 mg.kg-1, were measured simultaneously on the adductor muscles of the larynx and adductor… (More)
Is this relevant?
1992
1992
ORG-9426 is a new steroidal nondepolarizing neuromuscular blocking drug. We determined the dose-response relationship of ORG-9426… (More)
Is this relevant?
1991
1991
ORG 9426 is a new non-depolarizing steroidal muscle relaxant with a short onset time and intermediate duration of action. Its… (More)
Is this relevant?
1991
1991
To determine average dose requirements and pharmacodynamic characteristics before general clinical use, the dose-response curve… (More)
Is this relevant?
1990
1990
The neuromuscular blocking effects and pharmacokinetics of ORG 9426, 1.5 mg/kg and ORG 9616, 1.2 mg/kg iv, two new… (More)
Is this relevant?
1990
1990
Developmental research has been directed toward creating nondepolarizing muscle relaxants with an onset time and duration of… (More)
Is this relevant?